Overview This page contains the latest trade data of Heparin, salts, for therapeutic use. In 2023, Heparin, salts, for therapeutic use were the world's 789th most traded product, with a total trade of $4.64B. Between 2022 and 2023 the exports of Heparin, salts, for therapeutic use decreased by -15.9%, from $5.52B to $4.64B. Trade in Heparin, salts, for therapeutic use represent 0.021% of total world trade.
Heparin, salts, for therapeutic use are a part of Glands and Other Organs.
Exports In 2023 the top exporters of Heparin, salts, for therapeutic use were China ($795M), United States ($682M), Singapore ($631M), France ($605M), and Spain ($376M).
Imports In 2023 the top importers of Heparin, salts, for therapeutic use were France ($915M), Singapore ($536M), United States ($402M), Spain ($363M), and Hungary ($288M).
Ranking Heparin, salts, for therapeutic use ranks 1586th in the Product Complexity Index (PCI).
Description Heparin is a medication which is used to prevent blood clots. It is usually administered by injection or as a shot. Salts are used to control acid-base balance in the body, as well as for other therapeutic purposes.